Healthcare-associated Infections

Tracking CRE

CDC is working to better understand the true number of infections caused by these organisms in the US. CRE infections are not a nationally notifiable condition. Therefore, there is not a requirement to report to CDC. CDC collects information on CRE from two surveillance systems:

Emerging Infections Program (EIP) –
Healthcare Associated Infections Community Interface (HAIC) uses 10 sites across the country to determine which patients and community members have or are at risk for CRE and Acinetobacter.

Multi-site resistant Gram-negative Surveillance Initiative (MuGSI)

National Healthcare Safety Network (NHSN) – tracks healthcare–associated infections of more than 11,500 facilities nationwide.

Below is a map showing states with carbapenemase-producing CRE confirmed by CDC.

Carbapenemase-producing CRE in the United States

Map - Carbapenemase-producing Carbapenem-Resistant Enterobacteriaceae (CRE) in the United States

States with confirmed CRE cases caused by the KPC enzyme

Alabama
Arizona
Arkansas
California (including CRE caused by the NDM enzyme, VIM or IMP enzyme)
Colorado (including CRE caused by the NDM enzyme)
Connecticut
Delaware
Florida
Georgia
Illinois (including CRE caused by the NDM enzyme)
Indiana
Iowa
Kentucky
Louisiana
Maryland (including CRE caused by the NDM enzyme)
Massachusetts (including CRE caused by the NDM enzyme)
Michigan
Minnesota (including CRE caused by the NDM enzyme)
Mississippi
Missouri
Montana

Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island (including CRE caused by the NDM enzyme)
South Carolina
South Dakota
Tennessee
Texas
Utah
Virginia (including CRE caused by the NDM enzyme)
Washington (including CRE caused by the NDM enzyme, VIM enzyme)
West Virginia
Wisconsin
Wyoming